SVB Securities Analyst Recommendations & Stock Picks

Name: Community Performance Rating
Item: SVB Securities
Rating: 2.4
Author: MarketBeat

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at SVB Securities. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by SVB Securities.

Company	Date	Action	Brokerage	Rating	Price Target	Impact on Price
RLAY Relay Therapeutics	8/8/2023	Initiated by	SVB Securities	Outperform		Low
NUVL Nuvalent	8/8/2023	Initiated by	SVB Securities	Market Perform	$42.00	Low
IDYA IDEAYA Biosciences	8/8/2023	Initiated by	SVB Securities	Outperform	$33.00	Low
EXEL Exelixis	8/8/2023	Initiated by	SVB Securities	Market Perform	$18.00	Low
QTRX Quanterix	8/8/2023	Upgraded by	SVB Securities	Market Perform -> Outperform	$30.00	Low
NVCR NovoCure	8/4/2023	Initiated by	SVB Securities	Outperform	$51.00	Low
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
RETA Reata Pharmaceuticals	7/28/2023	Downgraded by	SVB Securities	Outperform -> Market Perform		Low
BLTE Belite Bio	7/26/2023	Initiated by	SVB Securities	Outperform	$25.00	Low
NBIX Neurocrine Biosciences	7/24/2023	Upgraded by	SVB Securities	Market Perform -> Outperform	$115.00 -> $125.00	Low
CYRX Cryoport	7/13/2023	Downgraded by	SVB Securities	Outperform -> Market Perform	$30.00 -> $10.00	Low
BMY Bristol-Myers Squibb	7/10/2023	Initiated by	SVB Securities	Market Perform	$66.00	Low
MLTX MoonLake Immunotherapeutics	6/26/2023	Target Raised by	SVB Securities		$28.00 -> $56.00	Low
DICE DICE Therapeutics	6/21/2023	Downgraded by	SVB Securities	Outperform -> Market Perform		Low
EHAB Enhabit	6/20/2023	Initiated by	SVB Securities	Underperform	$10.00	Low
PEPG PepGen	6/14/2023	Target Lowered by	SVB Securities		$33.00 -> $28.00	Low
UNH UnitedHealth Group	6/14/2023	Target Lowered by	SVB Securities		$625.00 -> $560.00	Low
KDNY Chinook Therapeutics	6/13/2023	Downgraded by	SVB Securities	Outperform -> Market Perform		Low
OCS Oculis	6/12/2023	Initiated by	SVB Securities	Outperform		Low
RETA Reata Pharmaceuticals	6/12/2023	Upgraded by	SVB Securities	Market Perform -> Outperform	$80.00 -> $115.00	Low
CVAC CureVac	6/8/2023	Initiated by	SVB Securities	Outperform	$13.00	Low
CSTL Castle Biosciences	6/5/2023	Target Lowered by	SVB Securities		$50.00 -> $35.00	Low
BPMC Blueprint Medicines	6/5/2023	Downgraded by	SVB Securities	Market Perform -> Underperform	$48.00 -> $43.00	Low
ELEV Elevation Oncology	5/30/2023	Upgraded by	SVB Securities	Market Perform -> Outperform	$5.00 -> $8.00	Low
UHS Universal Health Services	5/26/2023	Upgraded by	SVB Securities	Market Perform -> Outperform	$147.00 -> $170.00	Low
A Agilent Technologies	5/24/2023	Target Lowered by	SVB Securities	Outperform	$170.00 -> $145.00	Low
ARWR Arrowhead Pharmaceuticals	5/12/2023	Downgraded by	SVB Securities	Outperform -> Market Perform	$40.00	Low
TRHC Tabula Rasa HealthCare	5/10/2023	Upgraded by	SVB Securities	Market Perform -> Outperform	$7.00 -> $10.00	Low
VIR Vir Biotechnology	5/5/2023	Target Lowered by	SVB Securities		$43.00 -> $42.00	Low
REGN Regeneron Pharmaceuticals	5/5/2023	Target Lowered by	SVB Securities		$976.00 -> $895.00	Low
PRVA Privia Health Group	5/5/2023	Target Raised by	SVB Securities		$39.00 -> $40.00	Low
LNTH Lantheus	5/5/2023	Target Raised by	SVB Securities		$120.00 -> $127.00	Low
AMED Amedisys	5/5/2023	Target Lowered by	SVB Securities		$96.00 -> $81.00	Low
ALHC Alignment Healthcare	5/5/2023	Target Lowered by	SVB Securities		$24.00 -> $12.00	Low
AGIO Agios Pharmaceuticals	5/5/2023	Target Lowered by	SVB Securities		$37.00 -> $34.00	Low
ABCL AbCellera Biologics	5/5/2023	Target Lowered by	SVB Securities		$16.00 -> $15.00	Low
LLY Eli Lilly and Company	5/1/2023	Target Raised by	SVB Securities		$410.00 -> $458.00	Low
DHR Danaher	5/1/2023	Initiated by	SVB Securities	Outperform	$300.00	Low
HUM Humana	4/27/2023	Target Lowered by	SVB Securities		$640.00 -> $600.00	Low
ALVR AlloVir	4/26/2023	Target Raised by	SVB Securities		$16.00 -> $19.00	Low
PRTA Prothena	4/24/2023	Initiated by	SVB Securities	Outperform	$80.00	Low

MRUS Merus	4/17/2023	Target Raised by	SVB Securities	Outperform	$35.00 -> $48.00	Low
FDMT 4D Molecular Therapeutics	4/13/2023	Target Lowered by	SVB Securities	Market Perform	$14.00 -> $13.00	Low
BBIO BridgeBio Pharma	4/13/2023	Target Raised by	SVB Securities	Outperform	$25.00 -> $27.00	Low
ARWR Arrowhead Pharmaceuticals	4/12/2023	Upgraded by	SVB Securities	Market Perform -> Outperform	$21.00 -> $35.00	Low
CORT Corcept Therapeutics	4/11/2023	Initiated by	SVB Securities	Market Perform	$25.00	Low
IPHA Innate Pharma	4/10/2023	Target Raised by	SVB Securities		$9.00 -> $10.00	Low
PRDS Pardes Biosciences	4/4/2023	Downgraded by	SVB Securities	Outperform -> Market Perform		Low
ACLX Arcellx	3/30/2023	Target Raised by	SVB Securities		$35.00 -> $39.00	Low
REGN Regeneron Pharmaceuticals	3/27/2023	Upgraded by	SVB Securities	Market Perform -> Outperform	$834.00 -> $976.00	Low
INCY Incyte	3/24/2023	Upgraded by	SVB Securities	Underperform -> Market Perform	$61.00	Low
RAIN Rain Oncology	3/21/2023	Initiated by	SVB Securities	Outperform	$11.00	Low
PTCT PTC Therapeutics	3/17/2023	Initiated by	SVB Securities	Market Perform	$48.00	Low
CNTA Centessa Pharmaceuticals	3/17/2023	Initiated by	SVB Securities	Outperform	$6.00	Low
HALO Halozyme Therapeutics	3/16/2023	Downgraded by	SVB Securities	Outperform -> Market Perform	$42.00	Low
DBTX Decibel Therapeutics	3/15/2023	Downgraded by	SVB Securities	Outperform -> Market Perform	$7.00 -> $2.00	Low
SGEN Seagen	3/14/2023	Target Raised by	SVB Securities		$141.00 -> $229.00	Low
FULC Fulcrum Therapeutics	3/10/2023	Target Lowered by	SVB Securities		$18.00 -> $10.00	Low
MORF Morphic	3/8/2023	Target Raised by	SVB Securities		$45.00 -> $56.00	Low
ICPT Intercept Pharmaceuticals	3/3/2023	Target Raised by	SVB Securities		$17.00 -> $18.00	Low
ARGX argenx	3/3/2023	Target Raised by	SVB Securities		$430.00 -> $435.00	Low
AHCO AdaptHealth	3/1/2023	Target Lowered by	SVB Securities		$30.00 -> $23.00	Low
MDRX Veradigm	3/1/2023	Target Lowered by	SVB Securities		$24.00 -> $17.00	Low
RETA Reata Pharmaceuticals	3/1/2023	Target Raised by	SVB Securities		$35.00 -> $75.00	N/A
GPCR Structure Therapeutics	2/28/2023	Initiated by	SVB Securities	Outperform	$33.00	Low
IRON Disc Medicine Opco	2/28/2023	Initiated by	SVB Securities	Outperform	$36.00	Low
NKTR Nektar Therapeutics	2/24/2023	Target Lowered by	SVB Securities		$5.00 -> $3.00	N/A
BPMC Blueprint Medicines	2/24/2023	Target Lowered by	SVB Securities		$45.00 -> $38.00	Low
MRNA Moderna	2/24/2023	Downgraded by	SVB Securities	Market Perform -> Underperform	$111.00 -> $93.00	Low
IONS Ionis Pharmaceuticals	2/23/2023	Target Lowered by	SVB Securities		$34.00 -> $27.00	Low
TDOC Teladoc Health	2/23/2023	Upgraded by	SVB Securities	Market Perform -> Outperform	$34.00	Low
ABBV AbbVie	2/10/2023	Upgraded by	SVB Securities	Underperform -> Market Perform	$135.00 -> $153.00	Low
VRTX Vertex Pharmaceuticals	2/8/2023	Target Lowered by	SVB Securities		$374.00 -> $365.00	Low
CI The Cigna Group	2/8/2023	Target Lowered by	SVB Securities		$335.00 -> $309.00	Low
SGEN Seagen	2/6/2023	Downgraded by	SVB Securities	Outperform -> Market Perform	$162.00 -> $141.00	Low
META Meta Platforms	2/2/2023	Target Raised by	SVB Securities	Outperform	$220.00 -> $255.00	Low
AMGN Amgen	2/2/2023	Target Lowered by	SVB Securities		$282.00 -> $267.00	Low
DNLI Denali Therapeutics	1/30/2023	Initiated by	SVB Securities	Outperform	$50.00	Low
BHVN Biohaven	1/24/2023	Initiated by	SVB Securities	Outperform	$24.00	Low

MarketBeat Community Rating for SVB Securities

Community Ranking:		2.4 out of 5 ( 2.4 of 5 stars)
Outperform Votes:		2,897 (Vote Outperform)
Underperform Votes:		3,157 (Vote Underperform)
Total Votes:		6,054

MarketBeat's community ratings are surveys of what our community members think about SVB Securities and other research firms. Vote "Outperform" if you believe SVB Securities's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SVB Securities's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Stock Ratings Reports and Tools

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

Ratings for Popular Stocks:

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

SVB Securities Analyst Recommendations & Stock Picks

MarketBeat Community Rating for SVB Securities

Stock Ratings Reports and Tools

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info